换一批
换一批MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.
第一作者：
Qian-Yun,Shi
第一单位：
Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China; Clinical College of Nanjing Medical University, Nanjing, China.
作者：
主题词
老年人(Aged);B-淋巴细胞(B-Lymphocytes);中枢神经系统肿瘤(Central Nervous System Neoplasms);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);原癌基因蛋白质c-myc(Proto-Oncogene Proteins c-myc);回顾性研究(Retrospective Studies)
DOI
10.1093/jnen/nlx083
PMID
29044419
发布时间
2017-10-27
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
